
Syschem (India) Ltd. (SYSCHEM) Share Price Falls 9.86% Amid Market Volatility
Updated: 5 Aug 2026 • 9:27 am
Posted by:

Syschem (India) Ltd. Share Price fell 9.86% to Rs 30.81 today, with a market cap of Rs 183.26 crore.
Syschem (India) Ltd. Share Price experienced a significant decline today, falling by 9.86% to close at Rs 30.81. This drop comes amid broader market volatility, positioning the company within the Micro Cap category with a market capitalisation of Rs 183.26 crore. The decline was marked by a turnover of Rs 0.08 crore and a trading volume of 26,199 shares on the BSE. Despite the absence of a specific catalyst, the price action highlights the stock's vulnerability within the current market environment.
Syschem (India) Ltd. (SYSCHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 30.81 |
| Previous Close | Rs 34.18 |
| Today's Change | Rs -3.37 (-9.86%) |
| Day Open | Rs 33.83 |
| Day High | Rs 33.83 |
| Day Low | Rs 30.8 |
| Current Volume (BSE) | 26,199 |
| BSE Traded Volume | 26,199 |
| Combined NSE + BSE Volume | 26,199 |
| Turnover | Rs 0.08 crore |
| Market Capitalisation | Rs 183.26 crore |
| Market Cap Category | Micro Cap |
Syschem (India) Ltd. (SYSCHEM) traded at Rs 30.81. versus the previous close of Rs 34.18, a fall of 9.86%. The stock opened at Rs 33.83, reached Rs 33.83, touched Rs 30.8. Reported volume was 26,199.
Syschem (India) Ltd. (SYSCHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 183.26 crore |
| P/E Ratio | 29.82x |
| P/B Ratio | 1.27x |
| ROE | -66.17% |
| ROCE | -29.75% |
| EPS | Rs 1.15 |
| Dividend Yield | 0% |
Syschem (India) Ltd. was valued at a P/E ratio of 29.82x, a P/B ratio of 1.27x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -66.17% and ROCE of -29.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 1.15, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Syschem (India) Ltd. operates within the Pharmaceuticals & Drugs industry, part of the broader Healthcare sector. The company has a market capitalisation of Rs 183.26 crore and an enterprise value that reflects its current market position. The price-to-earnings (P/E) ratio stands at 29.82, slightly above the industry median of 25.82, suggesting a relatively higher valuation. The price-to-book (P/B) ratio is 1.27, below the industry median of 1.85, indicating a potentially undervalued position relative to its book value. The company's return on equity (ROE) and return on capital employed (ROCE) are negative, at -66.17% and -29.75% respectively, highlighting challenges in profitability and capital efficiency. The earnings per share (EPS) is Rs 1.15, with no dividend yield reported, reflecting a focus on reinvestment over shareholder payouts.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.82x |
| Benchmark Median P/E | 25.82x |
| Benchmark Average P/E | 80.86x |
| Benchmark P/E Range | 3.39x to 3,385.56x |
| Company P/B Ratio | 1.27x |
| Benchmark Median P/B | 1.85x |
| Company ROE | -66.17% |
| Benchmark Median ROE | 10.59% |
| Company ROCE | -29.75% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 183.26 crore |
| Benchmark Median Market Cap | Rs 146.67 crore |
Syschem (India) Ltd. (SYSCHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Syschem (India) Ltd. (SYSCHEM) has a P/E ratio of 29.82x, which is above the benchmark median of 25.82x, a difference of +15.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syschem (India) Ltd. (SYSCHEM) has a ROE of -66.17%, which is below the benchmark median of 10.59%, a difference of -724.83%. Syschem (India) Ltd. (SYSCHEM) has a ROCE of -29.75%, which is below the benchmark median of 12.98%, a difference of -329.2%.
Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Syschem (India) Ltd. is part of the Pharmaceuticals & Drugs industry within the Healthcare sector. The industry comprises 137 companies, with Syschem's P/E ratio of 29.82 slightly above the industry median of 25.82. The industry P/B ratio median is 1.85, with Syschem's P/B at 1.27, suggesting a relatively undervalued position. The company's ROE and ROCE are significantly below the industry medians of 10.59% and 12.98%, respectively, indicating challenges in operational efficiency. The industry benchmark includes companies with market capitalisations ranging from Rs 6.77 crore to Rs 2,945.17 crore, with Syschem positioned towards the lower end of this spectrum.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,835.92 | 0 | 2.35 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,589.99 | 0 | 3.07 | 0 | 5.36 |
Syschem (India) Ltd. (SYSCHEM) has a P/E ratio of 29.82x compared with the displayed peer median of 30.21x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -66.17% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at -29.75% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Syschem (India) Ltd. (SYSCHEM) has a market capitalisation of Rs 183.26 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Syschem (India) Ltd. faces competition from peers such as Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd. Among these, Syschem's P/E ratio of 29.82 is comparable to Dishman Carbogen's 30.21 but lower than Kwality Pharmaceuticals' 39.86. Syschem's P/B ratio of 1.27 is higher than Dishman Carbogen's 0.44 but significantly lower than Kwality Pharmaceuticals' 8.11. The negative ROE and ROCE of Syschem contrast with the positive figures of its peers, highlighting areas for potential improvement.
Why Investors Are Watching Syschem (India) Ltd.
Syschem (India) Ltd. has attracted attention due to its recent price fall and position within the competitive Pharmaceuticals & Drugs industry.
- Significant 9.86% price fall today, highlighting market volatility.
- Neutral RSI indicates balanced momentum.
- Higher P/E ratio suggests relative overvaluation.
- Negative ROE and ROCE highlight profitability challenges.
- Positioned in a competitive sector with notable peers.
Investors should monitor Syschem's ability to improve profitability and operational efficiency while navigating industry dynamics.
About Syschem (India) Ltd.
Syschem (India) Ltd. operates in the Pharmaceuticals & Drugs industry, focusing on the development and manufacturing of pharmaceutical products. The company is part of the Healthcare sector, which encompasses a wide range of medical and health-related services and products. Syschem's business model involves the production of various drugs and formulations, catering to both domestic and international markets. The company's operations are aligned with industry standards, aiming to deliver quality pharmaceutical solutions. Despite its smaller market capitalisation, Syschem competes with larger players in the industry, striving to enhance its market presence and product offerings.
Track Syschem (India) Ltd. Share Price on Univest
Use Syschem (India) Ltd. (SYSCHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track Syschem (India) Ltd. Share Price on Univest to stay updated with live market data. Univest provides comprehensive insights into technical indicators, fundamental ratios, shareholding patterns, and market trends. By following Syschem on Univest, users can gain valuable information to make informed investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused Syschem (India) Ltd. Share Price to fall today?
Ans. Syschem (India) Ltd. Share Price fell 9.86% today, but the data does not specify a particular catalyst for this decline. The drop reflects broader market volatility affecting the stock. The stock moved -9.86% during the session.
How does Syschem (India) Ltd.'s P/E ratio compare to the industry?
Ans. Syschem (India) Ltd.'s P/E ratio is 29.82, slightly above the industry median of 25.82, indicating a relatively higher valuation compared to peers. The company trades at a P/E ratio of 29.82x.
What is the market capitalisation of Syschem (India) Ltd.?
Ans. Syschem (India) Ltd. has a market capitalisation of Rs 183.26 crore, categorising it as a Micro Cap company within the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.
What are the profitability challenges for Syschem (India) Ltd.?
Ans. Syschem (India) Ltd. faces profitability challenges with a negative ROE of -66.17% and ROCE of -29.75%, indicating inefficiencies in generating returns. ROE stands at -66.17%. ROCE stands at -29.75%. The relevant peer median ROE is 10.59%.
How does Syschem (India) Ltd.'s P/B ratio compare to the industry?
Ans. Syschem (India) Ltd.'s P/B ratio is 1.27, below the industry median of 1.85, suggesting a potentially undervalued position relative to its book value. The company trades at a P/E ratio of 29.82x.
What sector does Syschem (India) Ltd. operate in?
Ans. Syschem (India) Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry, focusing on pharmaceutical product development. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.
Who are Syschem (India) Ltd.'s peers?
Ans. Syschem (India) Ltd.'s peers include Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd., among others in the Pharmaceuticals & Drugs industry. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
How does Syschem (India) Ltd.'s ROE compare to the industry?
Ans. Syschem (India) Ltd.'s ROE is -66.17%, significantly below the industry median of 10.59%, highlighting challenges in generating shareholder returns. ROE stands at -66.17%. ROCE stands at -29.75%. The relevant peer median ROE is 10.59%.
Recent Articles

Zota Health Care Share Price in Focus as Lyptus Punch-Card Fund Acquires 0.63 Percent Stake Worth Rs 27.18 Crore From Valiant India on 5 August 2026
5 August 2026

Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits New 52-Week High
5 August 2026

Sudeep Pharma Share Price in Focus as Goldman Sachs Acquires 1.04 Percent Stake Worth Rs 100 Crore From Nuvama Funds on 5 August 2026
5 August 2026

Pidilite Industries Ltd. (PIDILITIND) Share Price Hits Fresh 52-Week High
5 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Zota Health Care Share Price in Focus as Lyptus Punch-Card Fund Acquires 0.63 Percent Stake Worth Rs 27.18 Crore From Valiant India on 5 August 2026
Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits New 52-Week High
Sudeep Pharma Share Price in Focus as Goldman Sachs Acquires 1.04 Percent Stake Worth Rs 100 Crore From Nuvama Funds on 5 August 2026
Pidilite Industries Ltd. (PIDILITIND) Share Price Hits Fresh 52-Week High
RBI MPC August 2026: All 13 Experts in Moneycontrol Poll Expect Status Quo on Rates as Brent Crude Surge Dashes Rate Hike Hopes
Popular this week
Zota Health Care Share Price in Focus as Lyptus Punch-Card Fund Acquires 0.63 Percent Stake Worth Rs 27.18 Crore From Valiant India on 5 August 2026
Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits New 52-Week High
Sudeep Pharma Share Price in Focus as Goldman Sachs Acquires 1.04 Percent Stake Worth Rs 100 Crore From Nuvama Funds on 5 August 2026
Pidilite Industries Ltd. (PIDILITIND) Share Price Hits Fresh 52-Week High
RBI MPC August 2026: All 13 Experts in Moneycontrol Poll Expect Status Quo on Rates as Brent Crude Surge Dashes Rate Hike Hopes

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





